Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-13 10:06 am Unchanged |
2021-03-29 | 13D | Millendo Therapeutics, Inc. MLND |
New Enterprise Associates 15 L.P. | 117,760 9.300% |
0 (Unchanged) |
Filing History |
| 2021-04-07 5:25 pm Purchase |
2021-03-18 | 13G | Millendo Therapeutics, Inc. MLND |
Ikarian Capital LLC | 89,868 7.100% |
89,868 (New Position) |
Filing History |
| 2021-03-15 7:54 pm Purchase |
2021-03-03 | 13G | Millendo Therapeutics, Inc. MLND |
Citadel Advisors LLC | 61,777 4.900% |
61,777 (New Position) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND |
GREAT POINT PARTNERS LLC | 18,000 1.420% |
-97,317 (-84.39%) |
Filing History |
| 2021-02-16 07:02 am Unchanged |
2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND |
Roche Finance Ltd | 72,612 5.700% |
0 (Unchanged) |
Filing History |
| 2020-07-30 11:12 am Sale |
2020-07-23 | 13D | Millendo Therapeutics, Inc. MLND |
Bpifrance Participations S.A. | 39,340 3.100% |
-32,571 (-45.29%) |
Filing History |